Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia

The purpose of this study was to evaluate the effects of blonanserin, a novel antipsychotic, on cognitive function in first-episode schizophrenia. Twenty-four antipsychotic-naïve patients with first-episode schizophrenia participated in the study. Blonanserin was given in an open-label design for 8 ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human psychopharmacology 2012-01, Vol.27 (1), p.90-100
Hauptverfasser:	Tenjin, Tomomi, Miyamoto, Seiya, Miyake, Nobumi, Ogino, Shin, Kitajima, Rei, Ojima, Kazuaki, Arai, Jun, Teramoto, Haruki, Tsukahara, Sachiko, Ito, Yukie, Tadokoro, Masanori, Anai, Kiriko, Funamoto, Yasuyuki, Kaneda, Yasuhiro, Sumiyoshi, Tomiki, Yamaguchi, Noboru
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Analysis of Variance Antipsychotic Agents - pharmacology Antipsychotic Agents - therapeutic use blonanserin Chronic Disease cognition Cognition Disorders - drug therapy Cognition Disorders - etiology Cognitive ability Female Group dynamics Humans letter fluency Male Mental disorders Piperazines - pharmacology Piperazines - therapeutic use Piperidines - pharmacology Piperidines - therapeutic use Prospective Studies Psychiatric Status Rating Scales Quality of Life Schizophrenia Schizophrenia - drug therapy Schizophrenia - physiopathology Severity of Illness Index Single-Blind Method Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!